Authors:
Mathew, P
Valentine, MB
Bowman, LC
Rowe, ST
Nash, MB
Valentine, VA
Cohn, SL
Castleberry, RP
Brodeur, GM
Look, AT
Citation: P. Mathew et al., Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: A pediatric oncology group study, NEOPLASIA, 3(2), 2001, pp. 105-109
Authors:
Steen, RG
Helton, KJ
Horwitz, EM
Benaim, E
Thompson, S
Bowman, LC
Krance, R
Wang, WC
Cunningham, JM
Citation: Rg. Steen et al., Improved cerebrovascular patency following therapy in patients with sicklecell disease: Initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts, ANN NEUROL, 49(2), 2001, pp. 222-229
Authors:
Yeoh, EJA
Cunningham, JM
Yee, GC
Hunt, D
Houston, JA
Richardson, SL
Stewart, CF
Houghton, PJ
Bowman, LC
Gajjar, AJ
Citation: Eja. Yeoh et al., Topotecan-filgrastim combination is an effective regimen for mobilizing peripheral blood stem cells, BONE MAR TR, 28(6), 2001, pp. 563-571
Authors:
Leung, W
Pitts, N
Burnette, K
Cunningham, JM
Horwitz, EM
Benaim, E
Hale, G
Woodard, P
Pui, CH
Bowman, LC
Citation: W. Leung et al., Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome, BONE MAR TR, 27(7), 2001, pp. 717-722
Authors:
Hale, GA
Tong, X
Benaim, E
Cunningham, JM
Heslop, HE
Horwitz, EM
Leung, W
Rochester, RJ
Shearer, PD
Srivastava, DK
Woodard, JP
Bowman, LC
Citation: Ga. Hale et al., Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation, BONE MAR TR, 27(2), 2001, pp. 155-162
Authors:
Leung, WH
Turner, V
Richardson, SL
Benaim, E
Hale, G
Horwitz, EM
Woodard, P
Bowman, LC
Citation: Wh. Leung et al., Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors, HUMAN IMMUN, 62(4), 2001, pp. 399-407
Authors:
Leung, W
Hudson, MM
Strickland, DK
Phipps, S
Srivastava, DK
Ribeiro, RC
Rubnitz, JE
Sandlund, JT
Kun, LE
Bowman, LC
Razzouk, BI
Mathew, P
Shearer, P
Evans, WE
Pui, CH
Citation: W. Leung et al., Late effects of treatment in survivors of childhood acute myeloid leukemia, J CL ONCOL, 18(18), 2000, pp. 3273-3279
Authors:
Haight, AE
Bowman, LC
Ng, CYC
Vanin, EF
Davidoff, AM
Citation: Ae. Haight et al., Humoral response to vaccination with interleukin-2-expressing allogeneic neuroblastoma cells after primary therapy, MED PED ONC, 35(6), 2000, pp. 712-715
Authors:
Furman, WL
Stewart, CF
Poquette, CA
Pratt, CB
Santana, VM
Zamboni, WC
Bowman, LC
Ma, MK
Hoffer, FA
Meyer, WH
Pappo, AS
Walter, AW
Houghton, PJ
Citation: Wl. Furman et al., Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children, J CL ONCOL, 17(6), 1999, pp. 1815-1824
Authors:
Zamboni, WC
Bowman, LC
Tan, M
Santana, VM
Houghton, PJ
Meyer, WH
Pratt, CB
Heideman, RL
Gajjar, AJ
Pappo, AS
Stewart, CF
Citation: Wc. Zamboni et al., Interpatient variability in bioavailability of the intravenous formulationof topotecan given orally to children with recurrent solid tumors, CANC CHEMOT, 43(6), 1999, pp. 454-460
Authors:
Hale, GA
Heslop, HE
Bowman, LC
Rochester, RA
Pui, CH
Brenner, MK
Krance, RA
Citation: Ga. Hale et al., Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies, BONE MAR TR, 24(7), 1999, pp. 735-739
Authors:
Bowman, LC
Williams, R
Sanders, M
Ringwald-Smith, K
Baker, D
Gajjar, A
Citation: Lc. Bowman et al., Algorithm for nutritional support: Experience of the Metabolic and Infusion Support Service of St. Jude children's Research Hospital, INT J CANC, 1998, pp. 76-80